Two molecules
The ingredient and the product answer different medication questions
Semaglutide activates GLP-1 receptors, while tirzepatide activates both GIP and GLP-1 receptors. These pathways are involved in appetite and blood-sugar regulation. That distinction helps explain the medicines, but it cannot tell you which treatment you should receive. Your health history, other prescriptions, response and preferences all belong in the selection process.
The product name adds information that the ingredient alone cannot provide. Wegovy contains semaglutide and has weight-management indications, with both tablet and injectable formulations. Zepbound contains tirzepatide and has an adult weight-management indication. Ozempic and Mounjaro have diabetes indications. Products can share an ingredient yet have different approved uses, strengths and instructions; a familiar brand name is not permission to substitute one for another.
These are examples within a wider range of prescription options. For any proposal, ask for the exact medicine and formulation, its intended use and whether it is FDA-approved or compounded. Then check the practical terms: who prescribes, which pharmacy dispenses it, what follow-up is included and what you would pay. Medicine selection and the purchase of a program are connected decisions, but a package price does not establish that a drug is suitable.
